• iqvia
• 27 Nov, 2019

In the world of innovative oncology drug sales and marketing, the ability to foresee when an oncology patient is ready to start initial treatment or switch to next-line therapy represents fleeting moments of opportunity. These are the brief windows of time to link the right patients to the right treatments for the best possible outcomes. The challenge that sales and marketing teams face is identifying those moments before treatment decisions are made.
Read more...